Project Grant F31AI189061
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $147,486 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The New York Structural Biology Center, Inc. (NYSBC) to conduct research on the structural diversity and functional implications of viral RNA translation initiation elements, known as internal ribosome entry sites (IRES). The research aims to define the structural heterogeneity of HCV-like IRES elements across multiple...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $370,190 to San Diego State University Foundation to conduct research on the molecular mechanisms of viral nucleocapsid self-assembly and disassembly. The research aims to enhance fundamental understanding of these essential steps in the replication of RNA-packaging viruses, which could inform the development of new...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $438,500.00 in funding to the University of California, San Diego (UCSD) to conduct research on the sequence-specific determinants and impacts of interactions between the influenza A virus (IAV) protein NS2 and the viral polymerase. The research aims to expand upon prior work characterizing the IAV...
- This Project Grant award of $507,121 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to Duquesne University supports research on RNA homodimerization strand displacement pathways and their relationship to viral mechanisms. The research aims to characterize the structural, dynamic, and energetic details of kissing complexes and extended duplexes - two interconverting RNA structures implicated in processes like viral genome...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $502,043 to Brandeis University to investigate how metal ions affect the function of enzymes involved in viral pathogenesis and immune response regulation. The key objectives are to: 1) Dissect the metal-dependent activities of viral proteases from SARS-CoV-2, porcine reproductive and respiratory syndrome virus, hepatitis E...
- This Project Grant award from the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074) provides $335,268 to the University of Texas at Austin to investigate the evolutionary conservation of a group of viral proteins that help viruses evade the immune systems of a wide range of animals, including birds, reptiles, and insects. The research aims to uncover whether viruses have used similar immune evasion tactics for millions of years, even before humans existed. The...
- This Project Grant award of $249,000.00, issued on August 22, 2025, by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research on the role of host mRNA cleavage by RNase L in viral infections. The award recipient, The Ohio State University, will investigate the relationship between host mRNA cleavage by RNase L and translation in human cells, as well as the potential involvement of translation factors...
- This Project Grant award from the National Science Foundation's (NSF) Biological Sciences program provides $500,000 from March 2024 through February 2027 to researchers at the University of Maryland and Silvec Biologics, Inc. to develop methods to stabilize RNA genomes in viruses that can be used as therapies to treat plant diseases. The project aims to use computational approaches, including artificial intelligence, to design RNA structures that can be inserted into virus genomes to increase...
- This $300,000 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences will support research into the structural biology of RNA and RNA-protein interactions through May 2024. Funded under the Biological Sciences program (CFDA 47.074), this award to Vanderbilt University will utilize joint cryo neutron/x-ray crystallography techniques to better understand the importance of the 2'-hydroxyl group in RNA's expanded three-dimensional structure compared to DNA....
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program, provides $138,213 to The Trustees of Princeton University to conduct research on viral genetic interactions and mutations. Specifically, the research aims to systematically study the molecular mechanisms by which 4 strains of the lymphocytic choriomeningitis virus (LCMV) cause distinct impacts on the liver and...
CHARACTERIZING THE STRUCTURE AND FUNCTION OF A VIRAL RNA ELEMENT IN INHIBITING AN ANTIVIRAL PROTEIN - PROJECT SUMMARY RNA VIRUSES ARE A CONSTANT THREAT TO GLOBAL HEALTH AND UNDERSTANDING THEIR INTERACTIONS WITH HOST CELLS AT THE MOLECULAR LEVEL IS NECESSARY FOR IDENTIFYING THERAPEUTIC TARGETS. VIRUSES CONTAIN DIVERSE TYPES OF STRUCTURED RNA ELEMENTS WITHIN THEIR GENOMES WITH A VARIETY OF FUNCTIONS THAT ARE CRITICAL FOR SUCCESSFUL INFECTION. ONE SUCH STRUCTURED RNA ELEMENT WAS IDENTIFIED WITHIN POLIOVIRUS AND PROTECTS THE GENOMIC RNA FROM DEGRADATION BY THE MAMMALIAN ENDONUCLEASE, RIBONUCLEASE L (RNASE L). THIS RNA WAS FOUND TO BE A COMPETITIVE INHIBITOR OF RNASE L, PREVENTING DEGRADATION OF VIRAL GENOMIC RNA. PREVIOUS EXPERIMENTS HAVE CONFIRMED THE SECONDARY STRUCTURE OF THE POLIOVIRUS COMPETITIVE INHIBITOR RNA (CIRNA) AS WELL AS KEY TERTIARY CONTACTS REQUIRED FOR INHIBITION FUNCTION; HOWEVER, THE 3D STRUCTURE OF THE POLIOVIRUS CIRNA AND ITS SPECIFIC INTERMOLECULAR INTERACTIONS WITH RNASE L THAT ENABLE INHIBITION REMAIN UNRESOLVED. ADDITIONALLY, THE CIRNA ELEMENT WAS IDENTIFIED IN THE POLIOVIRUS GENOME BUT ITS PRESENCE IN DIVERGENT RNA VIRUSES HAS NOT BEEN EXPLORED OR CLASSIFIED. I HYPOTHESIZE THE CIRNA STRUCTURE DIRECTLY INHIBITS RNASE L BY PHYSICALLY BLOCKING ITS ACTIVE SITE. THE CIRNA RELIES ON CRUCIAL SECONDARY AND TERTIARY CONTACTS TO MAINTAIN ITS INHIBITORY PROPERTIES. I WILL IDENTIFY CIRNA ELEMENTS IN ADDITIONAL VIRAL GENOMES AND DEFINE THE PHYLOGENETIC DISTRIBUTION OF THIS CLASS OF RNAS. TO TEST THESE HYPOTHESES, I WILL USE A COMBINATION OF BIOPHYSICAL TECHNIQUES, STRUCTURAL BIOLOGY, BIOCHEMICAL ASSAYS, AND BIOINFORMATICS. AIM 1. I WILL USE A BIOINFORMATIC APPROACH TO QUERY A VIRAL GENOMIC DATABASE FOR CIRNA ELEMENTS AND TEST NEW PUTATIVE HITS FOR RNASE L INHIBITION ACTIVITY USING A FLUORESCENCE-BASED ASSAY. I WILL USE BIOCHEMICAL METHODS TO MAP THE BINDING SITE OF RNASE L ON CIRNA TO FIND THE CONSERVED BINDING SITE AMONG ALL EXAMPLES. AIM 2. I WILL CHARACTERIZE THE INTERACTION BETWEEN THE CIRNA AND RNASE L (AND THEIR MUTANTS) USING MICROSCALE THERMOPHORESIS TO QUANTIFY THE BINDING AFFINITY AND MEASURE THE STOICHIOMETRY BETWEEN THESE TWO MOLECULES AND BIOCHEMICALLY RELEVANT MUTANTS. TO FULLY CHARACTERIZE THIS INTERACTION ON A MOLECULAR LEVEL, I WILL USE CRYO-ELECTRON MICROSCOPY TO SOLVE THE STRUCTURE OF THE CIRNA-RNASE L COMPLEX. THE WORK OUTLINED IN THIS PROPOSAL WILL PROVIDE INSIGHT INTO HOW STRUCTURED RNA ELEMENTS DIRECTLY INTERACT WITH HOST PROTEIN FACTORS, AND HOW THESE HAVE EVOLVED IN THE VIRAL WORLD.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $49.5k | 8/25/25 | ||
| Not listed | $0 | 8/25/25 |